Abstract
The purpose of this report was to describe pseudolesions of the liver that mimicked residual hypervascular hepatocellular carcinoma (HCC), as observed on gadoxetate disodium-enhanced magnetic resonance imaging (EOB-MRI) obtained shortly after transarterial chemoembolization (TACE). Between June 2008 and December 2008, three patients underwent MRI within 12 days after TACE to rule out remaining viable cancerous tissue or to assess the treatment effect. In all three patients, nontumorous liver tissue adjacent to the treated HCC exhibited focal arterial enhancement on dynamic phase and subsequent diminished uptake of gadoxetate disodium on hepatocellular phase images, which mimicked residual HCC. All three patients had mild postembolization syndrome at the time of EOB-MRI and showed no evidence of residual or recurrent tumors on follow-up. The findings of these areas may represent transient focal hyperemia and damage to the liver cell function caused by TACE. Radiologists should be aware that EOB-MRI obtained shortly after TACE may show pseudolesions around the treated tumors and should not mistake them for residual or recurrent tumors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G, et al. Imoroved detection of focal liver lesions at MR imaging: gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004;230:266–275.
Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, et al. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 2009;192:1675–1681.
Shinozaki K, Yoshimitsu K, Irie H, Aibe H, Tajima T, Nishie A, et al. Comparison of test-injection method and fixed-time method for depiction of hepatocellular carcinoma using dynamic steady-state free precession magnetic resonance imaging. J Comput Assist Tomogr 2004;28:628–634.
Yoshimitsu K, Honda H. Dynamic MR imaging of the upper abdomen: timing optimization and pulse sequence selection. Nippon Igaku Hoshasen Gakkai Zasshi 2001;61:408–413 (in Japanese).
Kimura S, Okazaki M, Higashihara H, Haruno M, Nozaki Y, Urakawa H, et al. Clinico-roentgenologic findings in hepatocellular carcinoma fed by the right inferior phrenic artery at the initial chemoembolization. Hepatogastroenterology 2009;56:191–198.
Yamada R, Sawada S, Uchida H, Kumazaki T, Hiramatsu K, Ishii H, et al. Clinical study of porous gelatin sphere (YM670) in transcatheter arterial embolization. Jpn J Cancer Chemother 2005;32:1431–1436 (in Japanese).
Hemingway AP, Allison DJ. Complication of embolization: analysis of 410 patients. Radiology 1988;166:669–672.
Miyayama S, Mitsui T, Zen Y, Sudo Y, Yamashiro M, Okuda M, et al. Histopathological findings after ultraselective transcatheter arterial chemoembolization for hepatocellular carcinoma. Hepatol Res 2009;39:374–381.
Tsushima Y, Unno Y, Koizumi J, Kusano S. Hepatic perfusion change after transcatheter arterial embolization (TAE) of hepatocellular carcinoma: measurement by dynamic computed tomography (CT). Dig Dis Sci 1998;43:317–322.
Kamel IR, Liapi E, Reyes DK, Zahurak M, Bluemke DA, Geshwind JFH. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology 2009;250:466–473.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Shinagawa, Y., Sakamoto, K., Fujimitsu, R. et al. Pseudolesion of the liver observed on gadoxetate disodium-enhanced magnetic resonance imaging obtained shortly after transarterial chemoembolization for hepatocellular carcinoma. Jpn J Radiol 28, 483–488 (2010). https://doi.org/10.1007/s11604-010-0454-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-010-0454-9